Literature DB >> 15220269

Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema.

Michael S Ip1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15220269     DOI： 10.2337/diacare.27.7.1794

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

1.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

2.  Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.

Authors:  Oswaldo Ferreira Moura Brasil; Scott D Smith; Anat Galor; Careen Y Lowder; Jonathan E Sears; Peter K Kaiser
Journal:  Br J Ophthalmol       Date:  2006-11-15       Impact factor: 4.638

3.  Resource use and costs associated with diabetic macular edema in elderly persons.

Authors:  Alisa M Shea; Lesley H Curtis; Bradley G Hammill; Jonathan W Kowalski; Arliene Ravelo; Paul P Lee; Frank A Sloan; Kevin A Schulman
Journal:  Arch Ophthalmol       Date:  2008-12

Review 4.  Clinical trials on corticosteroids for diabetic macular edema.

Authors:  Hassan A Al Dhibi; J Fernando Arevalo
Journal:  World J Diabetes       Date:  2013-12-15

5.  Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study.

Authors:  Mustapha Norlaili; Shaharuddin Bakiah; Embong Zunaina
Journal:  BMC Ophthalmol       Date:  2011-11-23       Impact factor: 2.209

6.  Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro.

Authors:  Ashish Sharma; A Jayaprakash Patil; Navin Gupta; M F Estrago-Franco; Saffar Mansoor; Vincent Raymond; M Cristina Kenney; Baruch D Kuppermann
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

7.  In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.

Authors:  Akshaya Tatke; Narendar Dudhipala; Karthik Yadav Janga; Sai Prachetan Balguri; Bharathi Avula; Monica M Jablonski; Soumyajit Majumdar
Journal:  Nanomaterials (Basel)       Date:  2018-12-27       Impact factor: 5.076
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.